| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 44 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $31.12M | - | |
| CFO | 90.3K | $7.13M | - | |
| Other | 80.1K | $6.33M | - | |
| VP | 79.1K | $6.25M | - | |
| Other | 72.7K | $5.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Reeve Emma81 | Director | Sale+OE | 10,000 | $79.50 | $795,000.00 | -60.0% | -10.9% | - | |
| Nov 17, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,812 | $75.99 | $213,686.89 | -0.9% | -8.5% | - | |
| Nov 12, 2025 | Reeve Emma81 | Director | Sale+OE | 7,333 | $74.50 | $546,308.50 | -52.4% | -3.7% | - | |
| Oct 30, 2025 | Reeve Emma81 | Director | Sale+OE | 15,666 | $69.50 | $1,088,787.00 | -54.0% | +11.0% | - | |
| Oct 7, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 3,375 | $63.43 | $214,091.17 | -1.1% | +20.1% | - | |
| Oct 6, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 24,921 | $65.75 | $1,638,548.63 | -2.1% | +18.5% | - | |
| Oct 3, 2025 | Jacobson Allan Steven51 | Director | Sale+OE | 12,000 | $65.00 | $780,000.00 | -40.7% | +17.4% | - | |
| Oct 3, 2025 | Reeve Emma81 | Director | Sale+OE | 25,562 | $65.96 | $1,686,023.74 | -18.0% | +17.4% | - | |
| Oct 3, 2025 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 55,000 | $66.05 | $3,632,976.72 | -7.9% | +17.4% | - | |
| Sep 12, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 47,249 | $61.18 | $2,890,586.51 | -6.1% | +23.5% | - |